Lentiviral vectors can be used for full-length dystrophin gene therapy
Abstract Duchenne Muscular Dystrophy (DMD) is caused by a lack of dystrophin expression in patient muscle fibres. Current DMD gene therapy strategies rely on the expression of internally deleted forms of dystrophin, missing important functional domains. Viral gene transfer of full-length dystrophin...
Guardado en:
Autores principales: | John R. Counsell, Zeinab Asgarian, Jinhong Meng, Veronica Ferrer, Conrad A. Vink, Steven J. Howe, Simon N. Waddington, Adrian J. Thrasher, Francesco Muntoni, Jennifer E. Morgan, Olivier Danos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4e4bc5af0674a76abc106a806bbacbb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
HIV-1 sequences in lentiviral vector genomes can be substantially reduced without compromising transduction efficiency
por: Helin Sertkaya, et al.
Publicado: (2021) -
Necroptosis mediates myofibre death in dystrophin-deficient mice
por: Jennifer E. Morgan, et al.
Publicado: (2018) -
Publisher Correction: Necroptosis mediates myofibre death in dystrophin-deficient mice
por: Jennifer E. Morgan, et al.
Publicado: (2018) -
Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders
por: Naoya Uchida, et al.
Publicado: (2019) -
Visualization of cortical projection neurons with retrograde TET-off lentiviral vector.
por: Akiya Watakabe, et al.
Publicado: (2012)